Does the VerifyNow PRU value predict thrombotic and hemorrhagic events in patients undergoing flow diversion procedures on dual antiplatelet therapy?
VerifyNow PRU values may offer predictive value for thrombotic and hemorrhagic events during flow diversion procedures.
VerifyNow PRU values that correspond to platelet hyporesponse or hyper-response to dual antiplatelet therapy are associated with a higher risk of thrombotic and hemorrhagic events, respectively. Thus, the PRU value may offer some predictive value for these events.
Ajadi et al. (2019) studied this question.